- Home
- NAGE vs NOAH Comparison
NAGE vs NOAH Comparison
Compare NAGE & NOAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- NOAH
- Stock Information
- Founded
- NAGE 1999
- NOAH 2005
- Country
- NAGE United States
- NOAH China
- Employees
- NAGE N/A
- NOAH 1990
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- NOAH Investment Managers
- Sector
- NAGE Health Care
- NOAH Finance
- Exchange
- NAGE Nasdaq
- NOAH Nasdaq
- Market Cap
- NAGE 861.0M
- NOAH 750.3M
- IPO Year
- NAGE N/A
- NOAH 2010
- Fundamental
- Price
- NAGE $11.41
- NOAH $12.17
- Analyst Decision
- NAGE Strong Buy
- NOAH Buy
- Analyst Count
- NAGE 3
- NOAH 2
- Target Price
- NAGE $16.67
- NOAH $12.25
- AVG Volume (30 Days)
- NAGE 1.0M
- NOAH 196.8K
- Earning Date
- NAGE 08-06-2025
- NOAH 08-27-2025
- Dividend Yield
- NAGE N/A
- NOAH 4.75%
- EPS Growth
- NAGE N/A
- NOAH N/A
- EPS
- NAGE 0.18
- NOAH 0.96
- Revenue
- NAGE $107,925,000.00
- NOAH $353,619,651.00
- Revenue This Year
- NAGE $26.44
- NOAH N/A
- Revenue Next Year
- NAGE $20.06
- NOAH $6.50
- P/E Ratio
- NAGE $63.14
- NOAH $12.57
- Revenue Growth
- NAGE 29.77
- NOAH N/A
- 52 Week Low
- NAGE $2.52
- NOAH $7.21
- 52 Week High
- NAGE $14.69
- NOAH $14.90
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- NOAH 57.28
- Support Level
- NAGE N/A
- NOAH $11.13
- Resistance Level
- NAGE N/A
- NOAH $12.64
- Average True Range (ATR)
- NAGE 0.00
- NOAH 0.35
- MACD
- NAGE 0.00
- NOAH -0.09
- Stochastic Oscillator
- NAGE 0.00
- NOAH 68.54
About NAGE Niagen Bioscience Inc. Common Stock
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
About NOAH Noah Holdings Limited
Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.